Scarica l'app Stockscreener
9.685
10.34%
0.785
Precedente Chiudi:
$8.90
Aprire:
$9.98
Volume 24 ore:
295.74K
Relative Volume:
2.82
Capitalizzazione di mercato:
$262.77M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+35.08%
1M Prestazione:
-0.10%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$9.26
$10.46
Intervallo di 1 settimana:
$6.85
$10.46
Portata 52W:
$6.85
$18.79
Conexeu Sciences Inc Stock (CNXU) Company Profile
Nome
Conexeu Sciences Inc
Settore
Industria
Telefono
604-315-4722
Indirizzo
50 WEST LIBERTY STREET, SUITE 880, RENO
Compare CNXU vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNXU
Conexeu Sciences Inc
|
9.82 | 238.15M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
514.80 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
810.01 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
989.30 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
213.00 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
360.46 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Conexeu Sciences Inc Borsa (CNXU) Ultime notizie
CNXU : Conexeu Sciences Inc. Key Company Details - Zacks Investment Research
Conexeu Sciences (CNXU) Stock Trends and Sentiment 2026 - marketbeat.com
Top Conexeu Sciences (CNXU) Competitors 2026 - marketbeat.com
Conexeu Sciences (CNXU) investor reports 12.3% stake and warrant-linked shares - Stock Titan
Conexeu Sciences Inc. (CNXU) investor discloses 5.5% stake in Schedule 13G filing - Stock Titan
OnePointTwo Capital Ventures (CNXU) discloses 1.88M-share Conexeu Sciences stake - Stock Titan
Conexeu Sciences (CNXU) Stock Chart and Price History 2026 - marketbeat.com
One Platform, Five Markets: Insights into Conexeu Sciences Inc. - SmallCap Asia
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For - marketscreener.com
Conexeu to Present at 2026 Controversies & Conversations in Laser and Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration - marketscreener.com
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It - marketscreener.com
Conexeu Highlights ECM-Based Regenerative Platform Ahead of 2026 Aesthetics Symposium - tipranks.com
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration - The Manila Times
Beyond volume: Conexeu to discuss the body's repair process - Stock Titan
Conexeu Sciences Ord Shs (CNXU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Price to earnings forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One - Investing News Network
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison - IPO Edge
Conexeu Sciences (CNXU) logs $62,725 Rule 506(b) equity issuance for services - Stock Titan
Conexeu Sciences (CNXU) investor Michael G. Wright discloses 12.1% ownership stake - Stock Titan
Short Interest in Conexeu Sciences Inc. (NASDAQ:CNXU) Expands By 357.1% - MarketBeat
CNXU|Conexeu Sciences Ord Shs|Price:8.450|Chg%:-0.540 - TradingKey
Conexeu Sciences Inc. Revenue Breakdown – NASDAQ:CNXU - TradingView
Paisley Capital reports 1.8M-share position in Conexeu Sciences Inc. (CNXU) - Stock Titan
David Robert Bogart Net Worth (2026) - GuruFocus
Ana Lucia Bastiani Posner Net Worth (2026) - GuruFocus
Aaron Solomon Farberg Net Worth (2026) - GuruFocus
Jeffrey Nathan Sharpe Net Worth (2026) - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Conexeu Sciences Inc.Common Stock (CNXU) Stock Price, News, Quote & History - FinancialContent
Breakeven Is Near for Pulsar Group plc (LON:PULS) - simplywall.st
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
GLP-1 Aesthetic Care Projected to Reach $2B by 2030 - Stock Titan
CNXU Price Today: Conexeu Sciences Inc. Stock Price, Quote & Chart | MEXC - mexc.co
The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It. - PR Newswire
A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next - marketscreener.com
Bullish NeOnc Technologies Holdings Insider Buying Worth US$615.6k Yet To Pay Off - simplywall.st
Conexeu Sciences Launches CXU™ Platform for Injectable Aesthetics - Intellectia AI
Stocks & Markets Podcast: Regenerative Medicine’s Next Leap with Conexeu Sciences CEO - TheStreet Pro
Conexeu targets $2B injectable aesthetics marke... - Pluang
Conexeu Sciences Details Completion Of 12-Month P.R.O.O.F. Preclinical Study For CXU Platform - marketscreener.com
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It - The Manila Times
OneWater Marine Inc. (NASDAQ:ONEW): Is Breakeven Near? - simplywall.st
CNXU Stock Price and Chart — NASDAQ:CNXU - TradingView
Claudia Itze Chavez Munoz Net Worth (2026) - GuruFocus
Michael G. Wright Net Worth (2026) - GuruFocus
April Lynn Burke Net Worth (2026) - GuruFocus
Stephen Douglas Inouye Net Worth (2026) - GuruFocus
Conexeu Sciences (CNXU) Insider Trading Activity 2026 - MarketBeat
Flourish Adoption - AOL.com
CNXU Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Conexeu Sciences Inc Azioni (CNXU) Dati Finanziari
Non sono disponibili dati finanziari per Conexeu Sciences Inc (CNXU). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.92%
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):